Hyperliquid Strategies, Inc. (PURR)
8.31
-0.39
(-4.48%)
USD |
NASDAQ |
Nov 16, 16:00
8.22
-0.09
(-1.08%)
After-Hours: 20:00
Hyperliquid Strategies Enterprise Value : 2.010B for Nov. 16, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 16, 2026 | 2.010B |
| November 13, 2026 | 2.116B |
| November 12, 2026 | 2.145B |
| November 11, 2026 | 2.239B |
| November 10, 2026 | 2.130B |
| November 09, 2026 | 2.173B |
| November 06, 2026 | 2.147B |
| November 05, 2026 | 2.132B |
| November 04, 2026 | 2.386B |
| November 03, 2026 | 2.514B |
| November 02, 2026 | 2.391B |
| October 30, 2026 | 2.745B |
| October 29, 2026 | 3.094B |
| October 28, 2026 | 2.462B |
| October 27, 2026 | 2.429B |
| October 26, 2026 | 2.217B |
| October 23, 2026 | 2.138B |
| October 22, 2026 | 2.111B |
| October 21, 2026 | 2.367B |
| October 20, 2026 | 2.239B |
| October 19, 2026 | 2.190B |
| October 16, 2026 | 2.217B |
| October 15, 2026 | 2.416B |
| October 14, 2026 | 2.326B |
| October 13, 2026 | 2.533B |
| Date | Value |
|---|---|
| October 12, 2026 | 2.579B |
| October 09, 2026 | 2.773B |
| October 08, 2026 | 2.824B |
| October 07, 2026 | 2.942B |
| October 06, 2026 | 3.151B |
| October 05, 2026 | 3.266B |
| October 02, 2026 | 2.985B |
| October 01, 2026 | 3.023B |
| September 30, 2026 | 3.089B |
| September 29, 2026 | 2.253B |
| September 28, 2026 | 2.285B |
| September 25, 2026 | 2.439B |
| September 24, 2026 | 2.688B |
| September 23, 2026 | 2.658B |
| September 22, 2026 | 2.660B |
| September 21, 2026 | 2.580B |
| September 18, 2026 | 2.688B |
| September 17, 2026 | 2.435B |
| September 16, 2026 | 2.156B |
| September 15, 2026 | 2.108B |
| September 14, 2026 | 2.239B |
| September 11, 2026 | 2.190B |
| September 10, 2026 | 2.070B |
| September 09, 2026 | 2.275B |
| September 08, 2026 | 2.255B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Strive, Inc. (United States) | 2.722B |
| Meridian Holdings, Inc. (California) | 3.832M |
| ACADIA Pharmaceuticals, Inc. | 2.321B |
| Agenus, Inc. | 468.04M |
| Alnylam Pharmaceuticals, Inc. | 20.79B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 620.60M |
| Revenue (Quarterly) | 12.25M |
| Total Expenses (Quarterly) | -608.35M |
| EPS Diluted (Quarterly) | 2.542 |
| Earnings Yield | 38.52% |
| Operating Earnings Yield | 0.01% |
| Normalized Earnings Yield | -22.69 |